Literature DB >> 32843569

YAP Activation in Renal Proximal Tubule Cells Drives Diabetic Renal Interstitial Fibrogenesis.

Jianchun Chen1,2,3, Xiaoyong Wang2, Qian He2, Nada Bulus2, Agnes B Fogo2,4, Ming-Zhi Zhang2,3, Raymond C Harris1,2,3,5.   

Abstract

An increasing number of studies suggest that the renal proximal tubule is a site of injury in diabetic nephropathy (DN), and progressive renal tubulointerstitial fibrosis is an important mediator of progressive kidney dysfunction in DN. In this study, we observed increased expression and activation of YAP (yes-associated protein) in renal proximal tubule epithelial cells (RPTC) in patients with diabetes and in mouse kidneys. Inducible deletion of Yap specifically in RPTC or administration of the YAP inhibitor verteporfin significantly attenuated diabetic tubulointerstitial fibrosis. EGFR-dependent activation of RhoA/Rock and PI3K-Akt signals and their reciprocal interaction were upstream of proximal tubule YAP activation in diabetic kidneys. Production and release of CTGF in culture medium were significantly augmented in human embryonic kidney (HEK)-293 cells transfected with a constitutively active YAP mutant, and the conditioned medium collected from these cells activated and transduced fibroblasts into myofibroblasts. This study demonstrates that proximal tubule YAP-dependent paracrine mechanisms play an important role in diabetic interstitial fibrogenesis; therefore, targeting Hippo signaling may be a therapeutic strategy to prevent the development and progression of diabetic interstitial fibrogenesis.
© 2020 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32843569      PMCID: PMC7576565          DOI: 10.2337/db20-0579

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  65 in total

1.  TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm.

Authors:  A Vassilev; K J Kaneko; H Shu; Y Zhao; M L DePamphilis
Journal:  Genes Dev       Date:  2001-05-15       Impact factor: 11.361

2.  A Rho-kinase inhibitor, fasudil, prevents development of diabetes and nephropathy in insulin-resistant diabetic rats.

Authors:  Yuichi Kikuchi; Muneharu Yamada; Toshihiko Imakiire; Taketoshi Kushiyama; Keishi Higashi; Naomi Hyodo; Kojiro Yamamoto; Takashi Oda; Shigenobu Suzuki; Soichiro Miura
Journal:  J Endocrinol       Date:  2007-03       Impact factor: 4.286

3.  EGF Receptor-Dependent YAP Activation Is Important for Renal Recovery from AKI.

Authors:  Jianchun Chen; Huaizhou You; Yan Li; You Xu; Qian He; Raymond C Harris
Journal:  J Am Soc Nephrol       Date:  2018-08-02       Impact factor: 10.121

4.  G protein-coupled receptors engage the mammalian Hippo pathway through F-actin: F-Actin, assembled in response to Galpha12/13 induced RhoA-GTP, promotes dephosphorylation and activation of the YAP oncogene.

Authors:  Laura Regué; Fan Mou; Joseph Avruch
Journal:  Bioessays       Date:  2013-03-01       Impact factor: 4.345

Review 5.  Can we target tubular damage to prevent renal function decline in diabetes?

Authors:  Joseph V Bonventre
Journal:  Semin Nephrol       Date:  2012-09       Impact factor: 5.299

6.  Subcellular distribution and membrane association of Rho-related small GTP-binding proteins in kidney cortex.

Authors:  D Boivin; R Béliveau
Journal:  Am J Physiol       Date:  1995-08

7.  The extracellular matrix in the kidney: a source of novel non-invasive biomarkers of kidney fibrosis?

Authors:  Federica Genovese; Alba A Manresa; Diana Julie Leeming; Morten Asser Karsdal; Peter Boor
Journal:  Fibrogenesis Tissue Repair       Date:  2014-03-28

8.  Hippo pathway deficiency reverses systolic heart failure after infarction.

Authors:  John P Leach; Todd Heallen; Min Zhang; Mahdis Rahmani; Yuka Morikawa; Matthew C Hill; Ana Segura; James T Willerson; James F Martin
Journal:  Nature       Date:  2017-10-04       Impact factor: 49.962

9.  A RhoA-YAP-c-Myc signaling axis promotes the development of polycystic kidney disease.

Authors:  Jing Cai; Xuewen Song; Wei Wang; Terry Watnick; York Pei; Feng Qian; Duojia Pan
Journal:  Genes Dev       Date:  2018-06-11       Impact factor: 11.361

10.  Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts.

Authors:  Fernando Calvo; Nil Ege; Araceli Grande-Garcia; Steven Hooper; Robert P Jenkins; Shahid I Chaudhry; Kevin Harrington; Peter Williamson; Emad Moeendarbary; Guillaume Charras; Erik Sahai
Journal:  Nat Cell Biol       Date:  2013-05-26       Impact factor: 28.824

View more
  15 in total

1.  TAZ is important for maintenance of the integrity of podocytes.

Authors:  Jianchun Chen; Xiaoyong Wang; Qian He; Raymond C Harris
Journal:  Am J Physiol Renal Physiol       Date:  2022-02-14

2.  14-3-3ζ inhibits maladaptive repair in renal tubules by regulating YAP and reduces renal interstitial fibrosis.

Authors:  Tian-Tian Wang; Ling-Ling Wu; Jie Wu; Li-Sheng Zhang; Wan-Jun Shen; Ying-Hua Zhao; Jiao-Na Liu; Bo Fu; Xu Wang; Qing-Gang Li; Xue-Yuan Bai; Li-Qiang Wang; Xiang-Mei Chen
Journal:  Acta Pharmacol Sin       Date:  2022-07-15       Impact factor: 7.169

3.  Sestrin2 attenuates renal damage by regulating Hippo pathway in diabetic nephropathy.

Authors:  Yawei Bian; Chonglin Shi; Shan Song; Lin Mu; Ming Wu; Duojun Qiu; Jiajia Dong; Wei Zhang; Chen Yuan; Dongyun Wang; Zihui Zhou; Xuan Dong; Yonghong Shi
Journal:  Cell Tissue Res       Date:  2022-07-12       Impact factor: 4.051

4.  Knockdown of Krüppel-Like Factor 9 Inhibits Aberrant Retinal Angiogenesis and Mitigates Proliferative Diabetic Retinopathy.

Authors:  Ning Han; Lihong Zhang; Mi Guo; Li Yu
Journal:  Mol Biotechnol       Date:  2022-09-15       Impact factor: 2.860

Review 5.  New Insights into Hippo/YAP Signaling in Fibrotic Diseases.

Authors:  Masum M Mia; Manvendra K Singh
Journal:  Cells       Date:  2022-06-29       Impact factor: 7.666

6.  Bioinformatics analysis identifies diagnostic biomarkers and their correlation with immune infiltration in diabetic nephropathy.

Authors:  Menglan Huang; Zhengxi Zhu; Cong Nong; Zhao Liang; Jingxue Ma; Guangzhi Li
Journal:  Ann Transl Med       Date:  2022-06

Review 7.  Multifunctional regulatory protein connective tissue growth factor (CTGF): A potential therapeutic target for diverse diseases.

Authors:  Minyang Fu; Dandan Peng; Tianxia Lan; Yuquan Wei; Xiawei Wei
Journal:  Acta Pharm Sin B       Date:  2022-01-19       Impact factor: 14.903

Review 8.  The epidermal growth factor receptor axis and kidney fibrosis.

Authors:  Raymond C Harris
Journal:  Curr Opin Nephrol Hypertens       Date:  2021-05-01       Impact factor: 2.894

9.  Combined Luteolin and Indole-3-Carbinol Synergistically Constrains ERα-Positive Breast Cancer by Dual Inhibiting Estrogen Receptor Alpha and Cyclin-Dependent Kinase 4/6 Pathway in Cultured Cells and Xenograft Mice.

Authors:  Xiaoyong Wang; Lijuan Zhang; Qi Dai; Hongzong Si; Longyun Zhang; Sakina E Eltom; Hongwei Si
Journal:  Cancers (Basel)       Date:  2021-04-27       Impact factor: 6.639

10.  Ciliary Hedgehog signaling patterns the digestive system to generate mechanical forces driving elongation.

Authors:  Ying Yang; Pekka Paivinen; Chang Xie; Alexis Leigh Krup; Tomi P Makela; Keith E Mostov; Jeremy F Reiter
Journal:  Nat Commun       Date:  2021-12-10       Impact factor: 17.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.